Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
D B Hier, C A Mangone, R Ganellen, J D Warach, R Van Egeren, S J Perlik, P B Gorelic. Quantitative measurement of delta activity in Alzheimer's disease. Clinical EEG (electroencephalography). vol 22. issue 3. 1991-10-02. PMID:1879056. |
quantitative measurements of delta activity were made in 10 healthy elderly controls and 31 subjects with alzheimer's disease. |
1991-10-02 |
2023-08-11 |
human |
D B Hier, C A Mangone, R Ganellen, J D Warach, R Van Egeren, S J Perlik, P B Gorelic. Quantitative measurement of delta activity in Alzheimer's disease. Clinical EEG (electroencephalography). vol 22. issue 3. 1991-10-02. PMID:1879056. |
furthermore, delta activity was an excellent predictor of dementia severity within the 31 subjects with alzheimer's disease. |
1991-10-02 |
2023-08-11 |
human |
D B Hier, C A Mangone, R Ganellen, J D Warach, R Van Egeren, S J Perlik, P B Gorelic. Quantitative measurement of delta activity in Alzheimer's disease. Clinical EEG (electroencephalography). vol 22. issue 3. 1991-10-02. PMID:1879056. |
quantitative measurement of delta activity in alzheimer's disease. |
1991-10-02 |
2023-08-11 |
human |
D B Hier, C A Mangone, R Ganellen, J D Warach, R Van Egeren, S J Perlik, P B Gorelic. Quantitative measurement of delta activity in Alzheimer's disease. Clinical EEG (electroencephalography). vol 22. issue 3. 1991-10-02. PMID:1879056. |
delta activity did not discriminate between the healthy elderly controls and the early mild alzheimer's disease subjects. |
1991-10-02 |
2023-08-11 |
human |
D B Hier, C A Mangone, R Ganellen, J D Warach, R Van Egeren, S J Perlik, P B Gorelic. Quantitative measurement of delta activity in Alzheimer's disease. Clinical EEG (electroencephalography). vol 22. issue 3. 1991-10-02. PMID:1879056. |
in the t3 and t4 electrodes, delta activity in the moderate-to-advanced alzheimer subjects was 78.3% and 47.6% higher, respectively, than in control subjects. |
1991-10-02 |
2023-08-11 |
human |
L Minthon, L Edvinsson, R Ekman, L Gustafso. Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration. Journal of neural transmission. Supplementum. vol 30. 1990-10-04. PMID:1975266. |
the csf levels of somatostatin-li (sli), neuropeptide y (npy-li) and delta sleep inducing peptide (dsip-li) have been measured in patients with dementia of alzheimer type (dat) and dementia with frontotemporal degeneration of non-alzheimer type (ftd). |
1990-10-04 |
2023-08-11 |
Not clear |
C B Nemeroff, K R Krishnan, B M Belkin, J C Ritchie, C Clark, W W Vale, J E Rivier, M O Thorne. Growth hormone response to growth hormone releasing factor in Alzheimer's disease. Neuroendocrinology. vol 50. issue 6. 1990-03-07. PMID:2515465. |
although there was no difference between the magnitude of the grf-induced gh response (delta max gh response or area under the curve) between the alzheimer's disease patients and the controls, the alzheimer's patients exhibited a delayed gh response to grf. |
1990-03-07 |
2023-08-11 |
Not clear |
H Soininen, P J Riekkinen, J Partanen, E L Helkala, V Laulumaa, J Jolkkonen, K Reinikaine. Cerebrospinal fluid somatostatin correlates with spectral EEG variables and with parietotemporal cognitive dysfunction in Alzheimer patients. Neuroscience letters. vol 85. issue 1. 1988-05-27. PMID:2896317. |
in the subgroup of mild alzheimer cases csf somatostatin correlated positively also with alpha power, and the peak and the mean frequency, and negatively with theta power but not with delta activity. |
1988-05-27 |
2023-08-11 |
Not clear |
J M Hiller, Y Itzhak, E J Simo. Limbic regions of the brain of Alzheimer's disease patients show selective changes in mu, delta and kappa opioid receptor binding. NIDA research monograph. vol 75. 1988-03-18. PMID:2829002. |
limbic regions of the brain of alzheimer's disease patients show selective changes in mu, delta and kappa opioid receptor binding. |
1988-03-18 |
2023-08-11 |
Not clear |
A Ernst, H Cramer, D Strubel, F Kuntzmann, G A Schoenenberge. Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease. Journal of neurology. vol 235. issue 1. 1988-02-26. PMID:2448424. |
comparison of dsip- (delta sleep-inducing peptide) and p-dsip-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of alzheimer type, multi-infarct syndrome, communicating hydrocephalus and parkinson's disease. |
1988-02-26 |
2023-08-11 |
Not clear |
A Ernst, H Cramer, D Strubel, F Kuntzmann, G A Schoenenberge. Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease. Journal of neurology. vol 235. issue 1. 1988-02-26. PMID:2448424. |
the concentrations of delta sleep-inducing peptide (dsip)-like (dsip-li) and p-dsip-like (phosphorylated, ser7) immunoreactivity (p-dsip-li) were measured by specific radioimmunoassay in the cerebrospinal fluid (csf) of patients with senile dementia of the alzheimer type [sdat, subdivided into early (s1), middle (s2) and late dementia (s3)], multi-infarct dementia (md), parkinson's disease (pd), vascular disease (vd) and communicating hydrocephalus (h), as well as in control patients (c1, c2). |
1988-02-26 |
2023-08-11 |
Not clear |
J M Hiller, Y Itzhak, E J Simo. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain research. vol 406. issue 1-2. 1987-06-05. PMID:3032356. |
the amygdala of alzheimer's disease patients exhibited significantly lower levels of mu and delta binding (41% and 55% decrease, respectively). |
1987-06-05 |
2023-08-11 |
Not clear |
J M Hiller, Y Itzhak, E J Simo. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain research. vol 406. issue 1-2. 1987-06-05. PMID:3032356. |
total binding and binding to mu and delta receptors in frontal cortex, caudate and hippocampus of alzheimer's disease brains was indistinguishable from levels seen in these brain areas from control individuals. |
1987-06-05 |
2023-08-11 |
Not clear |
J M Hiller, Y Itzhak, E J Simo. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain research. vol 406. issue 1-2. 1987-06-05. PMID:3032356. |
selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in alzheimer's disease patients. |
1987-06-05 |
2023-08-11 |
Not clear |
P R Martin, R J Loewenstein, W H Kaye, M H Ebert, H Weingartner, J C Gilli. Sleep EEG in Korsakoff's psychosis and Alzheimer's disease. Neurology. vol 36. issue 3. 1986-03-28. PMID:3951711. |
alzheimer patients had significantly reduced delta sleep than controls. |
1986-03-28 |
2023-08-11 |
Not clear |
H Quadbeck, E Brostean. [Diagnostic value of electrophysiologic studies in presenile and senile dementia]. Zeitschrift fur Gerontologie. vol 16. issue 4. 1983-12-20. PMID:6636944. |
the occurrence of disorganized diffuse theta and delta waves instead of the regular alpha rhythm can signify alzheimer's disease. |
1983-12-20 |
2023-08-12 |
Not clear |
J Constantinidis, C Bouras, J Richar. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications. Clinical neuropathology. vol 2. issue 2. 1983-07-15. PMID:6189657. |
several neuropeptides should be involved in alzheimer's disease: substance p, endorphins, vasopressin, acth, somatostatin, vasoactive intestinal peptide, cholecystokinin, neurotensin, delta sleep-inducing peptide. |
1983-07-15 |
2023-08-12 |
human |